Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pierre Tariot

Clinical Neurophysiology Phoenix, AZ Medical Doctor

NPI 1568429025 CMS profile 298146

901 E Willetta St, 3Rd Floor, Phoenix, AZ 85006

Open in the dashboard

General payments

$438,142

241 records reported · program years 2019–2025

Research payments

$5,363

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,901,718 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Pierre Tariot of Phoenix, AZ is reported in the CMS Open Payments database as having received $438,142 across 241 general payments and $5,363 in research payments paid to them. Separately, studies naming them as principal investigator received $1,901,718 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Clinical Neurophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $74,167 33
2024 General $56,031 49
2024 Research $2,200 1
2023 General $37,882 39
2023 Research $3,163 2
2022 General $143,255 43
2021 General $36,033 24
2020 General $41,984 10
2019 General $48,790 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pierre Tariot
  • Clinical Neurophysiology median
  • Middle half of Clinical Neurophysiology
  • National median

In program year 2025, general payments to Pierre Tariot were reported at $74,167. Among 259 Clinical Neurophysiology profiles paid that year, the median was $435 and the middle half received between $121 and $1,917.

Show as a table
Year Pierre Tariot Clinical Neurophysiology median Middle half National median
2019 $48,790 $306 $88–$1,636 $163
2020 $41,984 $299 $85–$1,847 $114
2021 $36,033 $325 $96–$2,308 $132
2022 $143,255 $395 $106–$1,957 $149
2023 $37,882 $388 $120–$1,718 $160
2024 $56,031 $471 $137–$1,931 $164
2025 $74,167 $435 $121–$1,917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ACADIA Pharmaceuticals Inc $162,966 40 payments
  2. Novo Nordisk Inc $55,475 40 payments
  3. Eisai Inc. $30,297 31 payments
  4. Genentech, Inc. $28,750 8 payments
  5. AbbVie, Inc. $22,825 14 payments
  6. H. Lundbeck A S $22,738 17 payments
  7. E.R. Squibb & Sons, L.L.C. $21,750 10 payments
  8. Janssen Research & Development, LLC $20,500 6 payments
  9. Merck Sharp & Dohme Corporation $18,269 21 payments
  10. Otsuka Pharmaceutical Development & Commercialization, Inc. $9,838 6 payments
  11. Other $44,734 48 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $391,166 123 payments
  2. Travel and Lodging $22,230 44 payments
  3. Honoraria $14,410 6 payments
  4. Food and Beverage $5,688 65 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,648 3 payments
Products named General payments · program years 2019–2025
  1. NUPLAZID Parkinsons Disease Psychosis $106,825 16 payments
  2. NUPLAZID Parkinsons Disease Psychosis $30,270 15 payments
  3. REXULTI Psychiatry $24,526 24 payments
  4. DISEASE EDUCATION $12,500 1 payment
  5. ABILIFY MAINTENA $11,450 5 payments
  6. ACP-204 $8,800 2 payments
  7. ADLARITY $4,618 2 payments
  8. REXULTI Psychiatry $3,795 3 payments
  9. Dayvigo $1,800 1 payment
  10. MK-8931 $350 1 payment
  11. Other $21 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $5,363 3 payments

Records

244 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Neurophysiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record